INTRODUCTION
Currently, physical appearance is directly related to self-esteem, which also
influences the acceptance of others1. A
decrease of vascularization, the replacement of cells, fat atrophy, and loss of
muscle tonus are some of the factors that trigger skin aging2. In addition, the combination of genetic
factors (intrinsic aging) with environmental factors (photo aging) directly
influences skin aging, a common biological process, which triggers clinical
manifestations such as wrinkles, alteration of surface texture, and
pigmentation, among others3. Thus, the
treatment of facial rejuvenation is increasingly being exploited for a more
effective and lasting achievement1.
Aesthetic facial rejuvenation can be divided into operational and non-operational
procedures2. Operating procedures
include facial liposculpture surgery, a procedure in which the tissues are
carved with filling using intricate layers of infiltrated autologous tissue like
fat for example4.
The prevention and treatment of skin aging are leveraging technological
innovations in the cosmetic field; these innovations include mesotherapy and
platelet-rich plasma (PRP), a potential tool for skin rejuvenation, capable of
promoting the remodeling of the tissue as it is an autologous human platelet
concentrate in a small volume of plasma, containing large reservoirs of
bioactive proteins, including growth factors, which are able to facilitate
collagen fibroblasts, increasing the proliferation of keratinocytes and the
generation of hyaluronic acid, thus increasing, dermal elasticity1,3-5. In addition, a
study proved that PRP in conjunction with aesthetic facial fat filling
significantly reduced the post-treatment recovery time, thus favoring overall
patient satisfaction6.
OBJECTIVE
There are many methods and techniques used in the treatment of facial
rejuvenation, making it difficult to understand which facial therapies best
favor this rejuvenation. We conducted a systematic review to compare the
injection of platelet aggregates to other facial therapies in the facial
rejuvenation of adult patients.
METHODS
Protocol and record
This study protocol was recorded in the PROSPERO database (CRD42017075650)
and followed the recommendations of PRISM7, held from August to December 2017 at the Universidade
Positivo in Curitiba, Paraná, Brazil.
The following controlled vocabulary search (MeSH terms) and keywords of the
search strategy were established based on the acronym PICOS:
1. Population (P): Adult patients
2. Intervention (I): Injection of platelet aggregates Comparison (C): Other
facial therapies
3. Primary outcome (O): Facial rejuvenation
4. Study design (S): Randomized clinical trials (RCTs)
The search included indexed electronic databases such as PubMed, Scopus, Web
of Science, the Latin American Health Sciences Literature database (LILACS),
the Brazilian Library of Dentistry (BBO), and the Cochrane Library (Chart 1).
Chart 1 - Electronic databases and search strategy.
Pubmed= 714
(09/10/2017)
|
#1
((((((((((((Rejuvenation [MeSH Terms]) OR [MeSH
Terms]) OR "Skin Aging" [MeSH Terms]) OR "Adults
humans" [Title/Abstract]) OR "Adult
human" [Title/Abstract]) OR
Wrinkles [Title/Abstract]) OR ""Expression
marks" "[Title/Abstract])
|
#2 (((((((((((((((((((((Plasma
skin regeneration[MeSH Terms]) OR Platelet rich plasma[MeSH
Terms]) OR Fibrin[MeSH Terms]) OR Platelet aggregation[MeSH
Terms]) OR Blood platelets[MeSH Terms]) OR Injections[MeSH
Terms]) OR Injection[MeSH Terms]) OR Growth factors[MeSH
Terms]) OR "Plasma skin regeneration"[Title/Abstract]) OR
"Platelet rich plasma"[Title/Abstract]) OR
Fibrin[Title/Abstract]) OR "Platelet
aggregation"[Title/Abstract]) OR "Blood
platelets"[Title/Abstract]) OR Injections[Title/Abstract])
OR Injection[Title/Abstract]) OR "Growth
factors"[Title/Abstract]) OR "Platelet rich
fibrin"[Title/Abstract]) OR PRP[Title/Abstract]) OR
PRF[Title/Abstract]) OR "Skin regeneration"[Title/Abstract])
OR "Platelet concentration"[Title/Abstract]))
|
#3 ((randomized controlled
trial[pt] OR controlled clinical trial[pt] OR randomized
controlled trials[mh] OR random allocation[mh] OR
double-blind method[mh] OR single-blind method[mh] OR
clinical trial[pt] OR clinical trials[mh] OR ("clinical
trial"[tw]) OR ((singl*[tw] OR doubl*[tw] OR trebl*[tw] OR
tripl*[tw]) AND (mask*[tw] OR blind*[tw])) OR (placebos[mh]
OR placebo*[tw] OR random*[tw] OR research design[mh:noexp]
OR comparative study[pt] OR evaluation studies as topic[mh]
OR follow-up studies[mh] OR prospective studies[mh] OR
control*[tw] OR prospective*[tw] OR volunteer*[tw]) NOT
(animals[mh] NOT humans[mh])))
|
#1 AND #2 AND
#3
|
Scopus= 5467
(09/10/17)
|
#1 ( ( TITLE-ABS-KEY
( rejuvenation ) OR TITLE-ABS-KEY ( "Skin Aging" ) OR
TITLE-ABS-KEY ( "Adult human" ) OR TITLE-ABS-KEY ( wrinkles
) OR TITLE-ABS-KEY ( "Expression marks" ) ) )
|
#2 ( ( TITLE-ABS-KEY ( "Plasma
skin regeneration" ) OR TITLE-ABS-KEY ( "Platelet rich
plasma" ) OR TITLE-ABS-KEY ( "Platelet aggregation" ) OR
TITLE-ABS-KEY ( "Blood platelets" ) OR TITLE-ABS-KEY (
"Growth factors" ) OR TITLE-ABS-KEY ( injection ) OR
TITLE-ABS-KEY ( rejuvenation ) OR TITLE-ABS-KEY ( "Platelet
rich fibrin" ) OR TITLE-ABS-KEY ( prp ) OR TITLE-ABS-KEY (
prf ) OR TITLE-ABS-KEY ( "Skin regeneration" ) OR
TITLE-ABS-KEY ( "Platelet concentration" ) ) ) AND (
LIMIT-TO ( SUBJAREA , "MEDI " ) OR LIMIT-TO ( SUBJAREA ,
"PHAR " ) OR LIMIT-TO ( SUBJAREA , "DENT " ) )
|
#1 AND #2 |
Web of Science- 752
(09/10/2017)
|
#1 Topic:
(Rejuvenation) OR Topic: ("Skin Aging"") OR Topic:
("Adult human") OR Topic: (wrinkles) OR Topic: ("Expression
marks) ) )
|
#2 Topic: ("Plasma skin
regeneration") OR Topic: ("Platelet rich
plasma") OR Topic: (Fibrin)
OR Topic: ("Platelet aggregation")
OR Topic: ("Blood platelets")
OR Topic: (Injection*)
OR Topic: ("Growth
factORs") OR Topic:
("Platelet rich fibrin") OR Topic: ("Skin
regeneration") OR Topic: ("Platelet
concentration").
|
#1 AND #2 |
Lilacs and BBO= 03
(03/00) - (09/10/17)
|
#1
(((MH:Rejuvenation OR MH:"Skin Aging" OR "Adults humans" OR
"Adultos humanos" OR "Humanos Adultos" OR "Adult human" OR
"Adulto humano" OR "Humano adulto" OR Wrinkles OR Arrugas OR
Rugas OR "Expression marks" OR "Marcas de expression" OR
"Marcas de expressão")))
|
#2 (tw:((MH:"Plasma skin
regeneration" OR MH:"Platelet rich plasma" OR MH:Fibrin OR
MH:"Platelet aggregation" OR MH:"Blood platelets" OR
MH:Injections OR MH:Injection OR MH:"Growth factors" OR
"Platelet rich fibrin" OR "Plaquetas ricas em fibrina" OR
"Plaquetas ricas en fibrin" OR PRP OR PRF OR "Skin
regeneration" OR "Regeneração da pele" OR "Regeneración de
la piel" OR "Platelet concentration" OR "Concentração
plaquetaria" OR "Concentración plaquetaria")))
|
#1 AND #2 |
Cochrane Library =
181 (09/10/2017)
|
#1 MeSH descriptor:
[Rejuvenation] explode all trees #2 MeSH descriptor:
[Skin Aging] explode all trees #3 "Adults
humans":ti,ab,kw or "Adult Human" or Wrinkles or "Expression
Marks" (Word variations have been searched) #4 #1 or
#2 or #3
|
#5 MeSH descriptor: [Plasma Skin
Regeneration] explode all trees #6 MeSH descriptor:
[Platelet-Rich Plasma] explode all trees #7 MeSH
descriptor: [Fibrin] explode all trees #8 MeSH
descriptor: [Platelet Aggregation] explode all
trees #9 MeSH descriptor: [Blood Platelets] explode
all trees #10 MeSH descriptor: [Injections] explode
all trees #11 "Growth factors":ti,ab,kw or "Platelet
rich fibrin" or PRP or PRF or "Skin regeneration" (Word
variations have been searched) #12 "Platelet
concentration":ti,ab,kw (Word variations have been
searched) #13 #5 or #6 or #7 or #8 or #9 or #10 or
#11
|
#4 AND #13 |
Chart 1 - Electronic databases and search strategy.
In addition, a search was made in the gray literature including: abstracts of
the annual conference of the International Association for Dental Research
(IADR) and its regional divisions (1990-2017), ProQuest databases, Capes
Journals database, clinical trial records: Current Controlled Trials,
International Clinical Trials Registry Platform, ClinicalTrials.gov, and EU
Clinical Trials Register. No language, date, and publication restrictions
were applied.
Eligibility criteria
Randomized clinical trials (RCTs) with parallel or split face designs in
humans comparing the technical use of facial rejuvenation alone
versus the technical use of facial rejuvenation
together with platelet aggregates were included. The RCTs were excluded if:
1) they performed different rejuvenating treatments associated with platelet
aggregates on both sides; 2) the comparison of the use of the treatment
together or separate from the platelet aggregates was not directly related
to facial rejuvenation.
Study selection and data collection process
Articles were selected considering the titles first, followed by the
abstract, and then articles in their entirety, in accordance with the
eligibility criteria described. Relevant information from each article
selected such as the study design, number and age of participants,
interventions, evaluation time, and number of patients lost during treatment
(Chart 2), as well as the methods
of evaluations of the results (Chart 3) were extracted by researchers (C.F.AQ, C.T.T) using a
personalized file.
Chart 2 - Summary of studies selected for the systematic review.
Study (ID/year)
|
Study Design |
Mean age (±SD) |
Male patients |
Total number of patients |
Treatment |
Evaluation Time |
Patients lost |
Seied Omid Keyhan 2013 |
Clinical face divided |
46,5 ± 31,81 |
8 (32%) |
25 |
Fat + PRP Fat + FRP
|
1 and 12 months after the procedure |
0 |
Heba I Gawdat 2017 |
Clinical face divided |
41 ± 5,15 |
0 |
20 |
Side A (mesotherapy) Side B
(PRP)
|
1 and 6 months after the final session |
30% - 6 Patients
|
Qiang Hui 2016 |
Clinical face divided |
42,1 ± 7,37 |
0 |
13 |
Side PRP + Ultra-pulsed fractional
CO2 laser Saline side +
Ultra-pulsed fractional CO2 laser
|
3 months after the final session |
0 |
Min Kyung Shin 2012 |
Clinical pilot |
43,7 ± 6,0 |
0 |
22 |
11 - laser 11 - laser + PRP |
1 month after the final session |
0 |
Chart 2 - Summary of studies selected for the systematic review.
Chart 3 - Summary of the assessments made in each selected study.
Treatments |
Expectation |
Pictures |
Objective clinical evaluation |
OCT |
PSL |
Histological Analysis |
Adverse Effects |
Fat + PRP x Fat + FRP |
Filling/ Rejuvenation |
X |
X |
NR |
N.R |
NR |
X |
Mesotherapy x PRP |
Rejuvenation |
X |
X |
X |
X |
NR |
X |
CO2 Laser x CO2 Laser +
PRP
|
Rejuvenation |
X |
X |
NR |
X |
X |
X |
Laser x Laser + PRP |
Rejuvenation |
X |
X |
NR |
X |
NR |
X |
Chart 3 - Summary of the assessments made in each selected study.
Risk of bias of individual studies
The assays were examined using the Cochrane risk-of-bias tool of the Cochrane
Collaboration8.
The evaluation criteria included five items: suitable generation of
sequences, allocation concealment, blinding of evaluators and participants,
incomplete data results and reports, and selective outcome. The risk of bias
for each aspect of quality assessment was in accordance with the
recommendations described in the Cochrane Handbook for Systematic Reviews
5.1.0 (http://handbook.cochrane.org)8.
Two of the five areas of Cochrane risk of bias were considered as key areas
(randomization and allocation), thus qualifying the studies as “Low risk” of
bias if there was an adequate sequence generation and allocation
concealment. If one or more criteria were not met, the study would be
considered “high” risk of bias and judged as “undefined” when the authors
did not report how randomization or allocation was performed.
RESULTS
Study selection
After screening the databases and removing duplicates, 5918 studies were
identified (Figure 1). After the
removal by titles, 378 studies remained. This number was reduced to 10 after
reading the abstracts and full texts were evaluated to verify eligibility.
Among them, 6 were excluded: 1) four for not including rejuvenation9-12, 2) one for not comparing one technique to
another13, 3) one due to
unavailable full text14, and 1 pilot
clinical case was added because the information provided fit the proposed
subject5.
Figure 1 - Flowchart of the study.
Figure 1 - Flowchart of the study.
Characteristics of the studies included
The qualitative synthesis of the four studies included in this review
revealed that three presented a study design with a split face1,3,4 and
one was a pilot study5. The studies
included presented the following comparisons of Fat + PRP x Fat + FRP
(Fibrin Rich Plasma), in which the main expectation was facial rejuvenation
through facial filling in the cheek/malar region, to refine the facial
contour4; mesotherapy x PRP, in
which the expectation was facial rejuvenation by intradermal injection of a
solution of readymade growth factors - mesotherapy (side A) and PRP (side B)
to decrease the signs of aging such as wrinkles, sagging, and pigmentary
changes3(Chart 4).
Chart 4 - Summary of the results found in each study selected, in which
p<0.05 represents a statistically
significant difference.
Results |
Objective Clinical evaluation |
OCT |
PSL |
Histological Analysis |
Fat + PRP x Fat + FRP |
p < 0.05
|
N.R |
N.R |
NR |
Mesotherapy x PRP |
p > 0.05
|
p > 0.05
|
p < 0.05 + PRP
|
NR |
CO2 Laser x CO2 Laser +
PRP
|
p < 0.05
|
N.R |
p < 0.05 + PRP
|
NR |
Laser x Laser + PRP |
p > 0.05
|
N.R |
p > 0.05
|
p < 0.05 + PRP
|
Chart 4 - Summary of the results found in each study selected, in which
p<0.05 represents a statistically
significant difference.
In the study comparing mesotherapy x PRP, evaluations were performed by the
evaluators one and six months after the last treatment session by using the
Global Aesthetic Improvement Scale (GAIS) through a comparison of photos,
besides the Patient Satisfaction Level (PSL), registering their opinion on
the benefits of the treatment, and by Optical Coherence Tomography (OCT),
comparing epidermal and dermal thickness. Despite the absence of a
significant difference (p>0.05) in improvement between
the two treated areas by the GAIS and OCT, PSL was significantly higher
(p<0.05) in area B (PRP)3.
In the study with ultra-pulsed fractional CO2laser + injection of
PRP, evaluations were performed three months after the last treatment
session by using the VISIA Complexion Analysis System, also by the
comparison of photos, which presented a statistical difference in texture
and elasticity (p<0.05) that was higher for the side
with the application of ultra-pulsed fractional CO2laser +
injection of PRP. Moreover, the PSL of patients who registered their opinion
about the benefits of the treatment also showed no significant difference
(p<0.05), with results favorable to the ultra-pulsed
fractional CO2laser experimental group + injection of PRP1.
In the pilot study, the evaluations were performed one month after the last
treatment session, through the application of the GAIS Scale by evaluators
through comparison of photos and PSL, registering their opinion about the
benefits of the treatment; and, by the histological analysis in which 3 of 7
factors analyzed presented a statistically significant difference
(p<0.05), which were higher for the Fractional Laser
therapy + PRP5.
Regarding adverse effects, there were no cases of massive edema, prolonged
hematomas, or severe pain in the study of facial liposculpture surgery4. When comparing the mesotherapy and
PRP treatments, a transient erythema was observed on both sides, which
resolved in two days; there was a statistically significant difference in
relation to burning sensation (p> 0.01), which was
higher on the mesotherapy side3.
Erythema, edema, and crusting were evaluated, and were significantly (p
>0.05) lower on the ultra-pulsed fractional CO2laser + PRP
side1. In the pilot study, there
were no serious or persistent side effects during treatment. The duration of
erythema was 1-3 days, with no significant difference between the two groups
(p >0.05) 5.
Compared to the FRP, PRP presented lower efficacy in relation to the
maintenance of facial filling with fat. However, when associated with the
other treatment and when compared to mesotherapy, its effectiveness was
superior both in the improvement of rejuvenation and the reduction of
adverse effects.
Assessment of risk of bias
The assessment of risk of bias of the articles selected is shown in Figure 2. Some authors did not report how
concealment of allocation was performed. One study was determined to have a
“low» risk of bias (reference), one study presented an “undefined” risk of
bias, and the other two were classified as having a “high” risk of bias.
Figure 2 - Summary of risk of bias according to the Cochrane
Collaboration tool.
Figure 2 - Summary of risk of bias according to the Cochrane
Collaboration tool.
DISCUSSION
The main idea behind the use of platelet aggregates together with another
technique of facial rejuvenation involves the bioregenerative action of PRP that
stimulates the removal of components of the extracellular matrix and induces the
synthesis of new collagen by dermal fibroblasts, thus increasing skin
elasticity2,15. The present systematic review was
carried out to clarify this issue.
Half of the studies included in this systematic review reported no significant
differences in the results when comparing the two types of treatment3,5. Although all selected papers reported expected results in
accordance with the objective, the other key areas were classified as
“undefined” or with a “high” risk of bias, thus reducing the reliability of the
results.
Fat grafts have always been a challenge when inducing the necessary
neoangiogenesis in facial liposculpture surgery, which results in significant
resorption. Some studies have indicated that FRP provides better fat graft
survival compared to PRP due to its retention and the slow release of platelet
growth factors4.
To reduce this resorption, a study was carried out to compare the efficiency of
PRP versus FRP combined with a fat graft. The results indicated that FRP
associated with fat is more effective than a combination of PRP and fat. The
difficult injection technique and the lack of FRP fibrin clot are the main
disadvantages of FRP and fat compared to PRP4.
In a critical review of the current literature, five of the six selected studies
showed an improvement in fat graft survival with the addition of platelet
preparation16.
Liang et al.17assessed the efficacy of
nanofat-derived stem cells (NFSCs) in facial rejuvenation by intradermal
injection of nanofat combined with FRP applied in 103 patients compared to a
control group of 128 patients undergoing hyaluronic acid (HA) injections. They
concluded that both the injection of nanofat-FRP and HA showed an improvement in
the condition of the skin, but the first was associated with a greater patient
satisfaction, as well as an improvement in skin texture, suggesting that the
injection of nanofat-FRP is safe, highly effective, and a long-lasting method
for skin rejuvenation.
Compared to mesotherapy, PRP was superior due to increased patient satisfaction,
fewer side effects, and more sustainable results, without a significant
difference between the two areas treated regarding improvement according to GAIS
and OCT. However, the durability of PRP compared to mesotherapy needs to be
better evaluated, since the superiority of PRP was only perceived at the 6-month
follow-up. This suggests a shorter life of readymade products when compared to
the longevity of the effects of growth factors induced naturally by PRP, a point
that suggests more detailed research with longer follow-up periods3.
In addition to a reduction in adverse effects, several studies have reported that
PRP led to a clinical improvement when analyzing the effectiveness of PRP
combined with fractional carbon dioxide laser ablation in the treatment of
atrophic acne scars21. As the MTZ
produced by ultra-pulsed CO2 laser has similar histopathological
changes to those of wounds, laser therapy associated with PRP accelerates
healing and reduces the adverse effects1.
The results of a study involving PRP associated with an ablative carbon dioxide
laser showed that despite greater patient satisfaction, there was a greater
duration of adverse effects on the experimental side (with the association of
PRP), although this was not statistically significant. This worsening of adverse
effects can be attributed to the accumulated evidence, demonstrating that
platelets contribute to the initiation and propagation of the inflammatory
process18.
When PRP was combined with microneedling, no articles were found relating to
facial rejuvenation per se, but mostly, the safety and efficacy of treatment in
facial aesthetics was assessed, together with the improvement of post-acne
atrophic scars.
Facial harmonization is a set of aesthetic procedures that aim to harmonize the
teeth aesthetically and functionally with the mouth and face. Although it is not
yet a specialty in dentistry, it is important to know the definition of the area
of action, which, according to Resolution 176, dated September 6, 2016,
authorizes the use of botulinum toxin and facial fillers by a dental surgeon for
functional and/or aesthetic therapeutic purposes if they do not extrapolate
their anatomical area of activity.
Given that the clinical-anatomical area of the dental surgeon includes above the
hyoid bone, up to the nasal point (bones of the nose) and anterior to the
tragus, covering adjacent structures and the like, and for the cases of
non-surgical procedures, of the aesthetic purpose of facial harmonization in its
breadth, it also includes the upper third of the face.
Furthermore, according to resolution 158/2015 of the Federal Official Journal,
the Federal Council of Dentistry regulated the use of platelet aggregates for
non-transfusion purposes in dentistry, making it possible to collect blood to
obtain PRP and FRP in a dental or surgical center. This establishes that not
only dermatologists, but also the qualified dental surgeons, have the
possibility and competence to perform a facial rejuvenation treatment with the
use of platelet aggregates.
This systematic review showed that, due to the scarce evidence and the risk of
“undefined” bias, there is need for further research, especially randomized
controlled trials, that test alternatives to assess the best form of application
of platelet aggregates for facial rejuvenation.
Therefore, further randomized controlled clinical studies should be performed
that compare the use of platelet aggregates with other facial rejuvenation
techniques, since even with good results, few are found in the literature.
CONCLUSION
This systematic review found that there are few studies in the literature that
compare the use of platelet aggregates in facial rejuvenation, and those that
are available have an “undefined” or “high” risk of bias. Further well-designed
clinical studies are needed that compare the use of platelet aggregates
associated with facial rejuvenation techniques.
COLLABORATIONS
CLMS
|
Final manuscript approval, supervision.
|
CFA
|
Data curation, writing - original draft preparation.
|
LHKC
|
Data curation.
|
LMW
|
Analysis and/or data interpretation, conception and design study,
formal analysis.
|
JLG
|
Analysis and/or data interpretation, conception and design
study.
|
JCZ
|
Writing - review & editing.
|
REFERENCES
1. Hui Q, Chang P, Guo B, Zhang Y, Tao K. The Clinical Efficacy of
Autologous Platelet-Rich Plasma Combined with Ultra-Pulsed Fractional
CO2 Laser Therapy for Facial Rejuvenation. Rejuvenation Res.
2017;20(1):25-31. DOI: https://doi.org/10.1089/rej.2016.1823
2. Conde Montero E, Fernández Santos ME, Suárez Fernández R.
Platelet-rich plasma: applications in dermatology. Actas Dermosifiliogr.
2015;106(2):104-11. DOI:
https://doi.org/10.1016/j.ad.2013.12.021
3. Gawdat HI, Tawdy AM, Hegazy RA, Zakaria MM, Allam RS. Autologous
platelet-rich plasma versus readymade growth factors in skin rejuvenation: A
split face study. J Cosmet Dermatol. 2017;16(2):258-64. DOI:
https://doi.org/10.1111/jocd.12341
4. Keyhan SO, Hemmat S, Badri AA, Abdeshahzadeh A, Khiabani K. Use of
plate- let-rich fibrin and platelet-rich plasma in combination with fat graft:
which is more effective during facial lipostructure? J Oral Maxillofac Surg.
2013;71(3):610-21.
5. Shin MK, Lee JH, Lee SJ, Kim NI. Platelet-rich plasma combined with
fractional laser therapy for skin rejuvenation. Dermatol Surg.
2012;38(4):623-30. DOI:
https://doi.org/10.1111/j.1524-4725.2011.02280.x
6. Willemsen JCN, Van Dongen J, Spiekman M, Vermeulen KM, Harmsen MC,
van der Lei B, et al. The Addition of Platelet-Rich Plasma to Facial
Lipofilling: A Double-Blind, Placebo-Controlled, Randomized Trial. Plast
Reconstr Surg. 2018;141(2):331-43.
7. Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred
reporting items for systematic reviews and meta-analyses: the PRISMA statement.
BMJ. 2009;339:b2535. PMID: 19622551 DOI:
https://doi.org/10.1136/bmj.b2535
8. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et
al.; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The
Cochrane Collaboration’s tool for assessing risk of bias in randomised trials.
BMJ. 2011;343:d5928. DOI: https://doi.org/10.1136/bmj.d5928
9. Ibrahim MK, Ibrahim SM, Salem AM. Skin microneedling plus
platelet-rich plasma versus skin microneedling alone in the treatment of
atrophic post acne scars: a split face comparative study. J Dermatolog Treat.
2018;29(3):281-6. PMID: 28782384
10. Nofal E, Helmy A, Nofal A, Alakad R, Nasr M. Platelet-rich plasma
versus CROSS technique with 100% trichloroacetic acid versus combined skin
needling and platelet rich plasma in the treatment of atrophic acne scars: a
comparative study. Dermatol Surg. 2014;40(8):864-73.
11. Chawla S. Split Face Comparative Study of Microneedling with PRP
Versus Mi- croneedling with Vitamin C in Treating Atrophic Post Acne Scars. J
Cutan Aesthet Surg. 2014;7(4):209-12. DOI:
https://doi.org/10.4103/0974-2077.150742
12. Asif M, Kanodia S, Singh K. Combined autologous platelet-rich plasma
with microneedling verses microneedling with distilled water in the treatment of
atrophic acne scars: a concurrent split-face study. J Cosmet Dermatol.
2016;15(4):434-43. PMID: 26748836
13. Hersant B, SidAhmed-Mezi M, Niddam J, La Padula S, Noel W, Ezzedine
K, et al. Efficacy of autologous platelet-rich plasma combined with hyaluronic
acid on skin facial rejuvenation: A prospective study. J Am Acad Dermatol.
2017;77(3):584-6. PMID: 28807118
14. Kang BK, Shin MK, Lee JH, Kim NI. Effects of platelet-rich plasma on
wrinkles and skin tone in Asian lower eyelid skin: preliminary results from a
prospective, randomised, split-face trial. Eur J Dermatol.
2014;24(1):100-1.
15. Arshdeep, Kumaran MS. Platelet-rich plasma in dermatology: boon or a
bane? Indian J Dermatol Venereol Leprol. 2014;80(1):5-14. PMID:
24448117
16. Sclafani AP, Azzi J. Platelet Preparations for Use in Facial
Rejuvenation and Wound Healing: A Critical Review of Current Literature.
Aesthetic Plast Surg. 2015;39(4):495-505. DOI:
https://doi.org/10.1007/s00266-015-0504-x
17. Liang ZJ, Lu X, Li DQ, Liang YD, Zhu DD, Wu FX, et al. Precise
Intradermal Injection of Nanofat-Derived Stromal Cells Combined with
Platelet-Rich Fibrin Improves the Efficacy of Facial Skin Rejuvenation. Cellular
physiology and biochemistry. Cell Physiol Biochem. 2018;47(1):316-29. DOI:
https://doi.org/10.1159/000489809
18. Zhu JT, Xuan M, Zhang YN, Liu HW, Cai JH, Wu YH, et al. The efficacy
of autologous platelet-rich plasma combined with erbium fractional laser therapy
for facial acne scars or acne. Mol Med Rep. 2013;8(1):233-7. PMID: 23653117 DOI:
https://doi.org/10.3892/mmr.2013.1455
1. Universidade Positivo, Escola de Ciências
da Saúde, Curitiba, PR, Brazil.
Corresponding author: Carmen Lucia Mueller Storrer,
Rua Professor Pedro Viriato Parigot de Souza, 5300, Campo Comprido, Curitiba,
PR, Brazil, Zip Code: 81280-330. E-mail: carmen.storrer@gmail.com
Article received: December 13, 2018.
Article accepted: February 10, 2019.
Conflicts of interest: none.